v3.25.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 263,338 $ 530,230
Marketable securities 468,141 392,888
Restricted cash 10,681 10,626
Accounts receivable 44,510 108,285
Inventory 10,263 8,749
Prepaid expenses and other current assets 71,095 78,164
Total current assets 868,028 1,128,942
Property and equipment, net 133,538 138,413
Right of use asset, net 157,495 161,585
Goodwill 112,027 107,478
Other non-current assets 21,904 24,000
Total assets 1,292,992 1,560,418
Current liabilities:    
Accounts payable 34,162 41,579
Accrued expenses 132,165 211,165
Deferred revenue 108,334 675,067
Current portion of finance lease liabilities 5,478 7,009
Other current liabilities 142,031 219,596
Total current liabilities 422,170 1,154,416
Deferred revenue 409,557 446,819
Convertible notes payable 170,126 169,684
Non-current finance lease liabilities 53,055 53,726
Other non-current liabilities 313,727 359,614
Total liabilities 1,368,635 2,184,259
Commitments and contingencies (Note 15)
Preferred stock, $0.01 par value, 2,000,000 shares authorized at March 31, 2025 and December 31, 2024; no shares issued and outstanding at March 31, 2025 and December 31, 2024 0 0
Stockholders' deficit:    
Common stock, $0.01 par value, 600,000,000 shares authorized at March 31, 2025 and December 31, 2024; 164,206,386 shares issued and 161,957,868 shares outstanding at March 31, 2025 and 161,942,677 shares issued and 160,421,136 shares outstanding at December 31, 2024 1,642 1,619
Additional paid-in capital 4,512,849 4,501,403
Accumulated deficit (4,489,804) (5,008,450)
Treasury stock, cost basis, 2,248,518 shares at March 31, 2025 and 1,521,541 shares at December 31, 2024 (101,938) (95,854)
Accumulated other comprehensive income 1,608 (22,559)
Total stockholders’ deficit (75,643) (623,841)
Total liabilities and stockholders’ deficit $ 1,292,992 $ 1,560,418